Now, Salk researchers have demonstrated in mice that haemophilia B can be treated for life with one single injection, containing disease-free liver cells that can produce their missing clotting factor.
Genomics has the potential to significantly improve the efficacy of drugs and develop targeted therapies.
The link between cancer mutations and DNA repair mechanisms has been well established. However, the specific origins of the mutation in these essential pathways have remained enigmatic. Now, researchers have used human and worm data to explore the mutational causes of cancer.
Thermo Fisher Scientific has signed agreements with Takeda Pharmaceuticals and Daiichi Sanyo that will enable the Japanese firms to leverage Thermo Fisher’s FDA approved Oncomine Dx Target Test for their clinical trials and drug development programs.
Gilead Sciences will partner with Google Parent Alphabet’s Verily Life Sciences over the next three years, applying Verily’s Immunoscape platform to better understand the immunological basis of three common diseases.
An FDA-approved drug originally designed to treat cancer may be an unlikely potential ally in the global fight against tuberculosis, a new study suggests.
Doctors in Germany have for the first time, successfully treated twins in utero using a biotech drug, pointing to a new way to eliminate disease.
Less than half the patients diagnosed with cancer respond favourably to chemotherapy. Now, a new method for testing how patients will respond to various drugs could pave the way for more personalised treatment.
As a post-antibiotic future beckons, how can humanity protect itself against the proliferation of superbugs? Research suggests ‘drug sanctuaries’ in hospitals could be a promising solution.
CMO and Senior VP of Global Medical at Amgen, John Tsai, MD, is moving to Novartis to act as their new CMO and Head of Global Drug Development (GDD).
13 European countries have committed to work together and ensure secure and authorised cross-border access to genomic and other health data.
In a rare move, the agency is looking into whether Southern Illinois University allowed experimental vaccine research to occur on university grounds—without safety precautions.
General Electric aims to build on its existing expertise in biotech manufacturing by delivering a “factory-in-a-box” service specifically for viral vector-based medicine.
New data indicates that newly diagnosed lung cancer patients have a 50% increase in survival rate over 1 year when receiving Keytruda over traditional chemotherapy.